Drug Industry Antitrust Act. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Seventh Congress, first session, on Dec. 7-9, 1961. Part 4, Pharmaceutical Manufacturers Association :
Continuation of hearings on S. 1552, the Drug Industry Antitrust Act, to make essential drugs available to the public at reasonable prices through the establishment of quality standards, periodic drug production inspections, and penalties for anticompetitive activities.
| Corporate Authors: | , |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O.,
1961.
|
| Series: | U.S. Congressional Hearings.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Continuation of hearings on S. 1552, the Drug Industry Antitrust Act, to make essential drugs available to the public at reasonable prices through the establishment of quality standards, periodic drug production inspections, and penalties for anticompetitive activities. Considers (87) S. 1552. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC. Electronic resource. |
| Physical Description: | 1 online resource. |
| Format: | System requirements: PDF reader software. |